Inactive Instrument

Other languages ACCM SCIE OTC Markets

Equities

AccuStem Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-20
AccuStem Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-22
AccuStem Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13
AccuStem Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
AccuStem Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Accustem Sciences, Inc. and Emeritusdx Announce Joint Product Development Agreement and Strategic Partnership	23-07-17
Accustem Sciences Inc. Announces Resignation of Jeff Fensterer as Chief Operating Officer, Effective as of June 16, 2023	23-06-09
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals	23-06-06
Accustem Sciences Inc. Announces Strategic Clinical and Operational Partnership	23-05-31
Accustem Sciences Inc. Appoints Sean McDonald to Its Board of Directors	22-11-16
Accustem Sciences Inc. Appoints Wendy Blosser as Director to Serve on the Board	22-04-05
AccuStem to Build Corporate Headquarters in Phoenix, Arizona	22-03-04
AccuStem Sciences, Inc. Appoints New Executive Leadership Team	22-03-04
AccuStem Sciences, Inc. Appoints Wendy Blosser as Chief Executive Officer	22-03-04

No results for this search